Paroxetine in human breast milk and nursing infants

American Journal of Psychiatry

Volumn 157, Issue 2, 2000, Pages 185-189

  Stowe, Zachary N ^a   Cohen, Lee S ^b   Hostetter, Amy ^b   Ritchie, James C ^b   Owens, Michael J ^b   Nemeroff, Charles B ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BREAST FEEDING; BREAST MILK; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG MILK LEVEL; FEMALE; HUMAN; INFANT; PERINATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

BREAST FEEDING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; MILK, HUMAN; PAROXETINE; PREGNANCY; PUERPERAL DISORDERS;

EID: 0033980550     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.2.185     Document Type: Article

References (22)

1. Wisner KL, Perel JM, Findling RL: Antidepressant treatment during breast-feeding. Am J Psychiatry 1996; 153:1132-1137
2. Jensen PN, Olesen OV, Bertelsen A, Linnet K: Citalopram and desmethylcitalopram in breast milk and in serum of mother and infant. Ther Drug Monit 1997; 19:236-239
3. Burch KJ, Wells BG: Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 1992; 89:676-677
4. Isenberg KE: Excretion of fluoxetine in human breast milk (letter). J Clin Psychiatry 1990; 51:169
5. Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W: Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 1993; 32:1253-1255
6. Wright S, Dawling S, Ashford JJ: Excretion of fluvoxamine in breast milk. BrJ Clin Pharmacol 1991; 31:209
7. Spigset O, Carleborg L, Norstrom A, Sandlund M: Paroxetine level in breast milk (letter). J Clin Psychiatry 1996; 57:39
8. Altshuler LL, Burt VK, McMullen M, Hendrick V: Breastfeeding and sertraline: a 24 hour analysis. J Clin Psychiatry 1995; 56: 243-245
9. Mammen OK, Perel JM, Rudolph G, Foglia JP, Wheeler SB: Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 1997; 58:100-103
10. Ilett KF, Hackett LP, Dusci LJ, Roberts MJ, Kristensen JH, Paech M, Groves A, Yapp P: Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br J Clin Pharmacol 1998:45:459-462
11. Taddio A, Ito S, Koren G: Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 1996; 36:42-47
12. Kim J, Misri S, Riggs KW, Ryan DM, Carter D, Rurak DW: Stereoselective excretion of fluoxetine and norfluoxetine in breast milk and neonatal exposure, in 1997 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1997, pp 127-128
13. Yoshida K, Smith B, Craggs M, Kumar RC: Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998; 172:175-178
14. Eppersen CN, Anderson GM, McDougle CJ: Sertraline and breast-feeding (letter). N Engl J Med 1997; 336:1189-1190
15. Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A, Nemeroff CB: Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997; 154: 1255-1260
16. Wisner KL, Perel JM, Blumer J: Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998; 155:690-692
17. Llewellyn AM, Stowe ZN, Nemeroff CB: Infant outcome after sertraline exposure, in 1997 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 1997, p 176
18. Misri S, Carter D, Ryan DM: Paroxetine levels in mother/infant dyad, in 1999 Annual Meeting Syllabus and Proceedings Summary. Washington, DC, American Psychiatric Association, 1999, p 100
19. Wisner KL, Perel JM, Findling RL, Hinnes RL: Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns. Psychopharmacol Bull 1997; 33:249-251
20. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB: Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997; 283: 1305-1322
21. Bolden-Watson C, Richelson E: Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 1993; 52:1023-1029
22. Cusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 1994; 114:559-565